Workflow
Reuters
icon
Search documents
Novo Nordisk plunge wipes $50 billion off obesity drug giant
Reuters· 2026-02-04 13:21
Novo Nordisk shares tumbled 16% on Wednesday, wiping off around $50 billion from the Wegovy maker's market capitalization after it warned on Tuesday its sales and profits would fall in 2026. ...
Cencora beats quarterly profit estimates on strong demand for specialty medicines
Reuters· 2026-02-04 13:20
Core Insights - Cencora exceeded Wall Street profit estimates for the first quarter, driven by strong demand for specialty medicines and GLP-1 therapies [1] Company Performance - Cencora reported a profit that surpassed analyst expectations, indicating robust financial health and operational efficiency in the current market [1] Industry Trends - The sustained demand for specialty medicines and GLP-1 therapies highlights a growing trend in the pharmaceutical industry, suggesting potential for continued growth in these segments [1]
CDW beats fourth-quarter estimates on resilient demand for IT solutions
Reuters· 2026-02-04 13:15
Core Viewpoint - CDW exceeded fourth-quarter sales and profit expectations, driven by continued client investments in artificial intelligence and cloud adoption [1] Group 1: Financial Performance - CDW reported better-than-expected sales and profit figures for the fourth quarter [1]
Live Nation to acquire Italy's ForumNet, valued at $106 million
Reuters· 2026-02-04 13:14
Group 1 - Live Nation Entertainment has agreed to acquire ForumNet, a venue operator based in Italy, from holding firm Bastogi [1] - This acquisition aims to strengthen Live Nation's presence in the Italian live entertainment market [1]
Biotech firm Bio-Techne beats quarterly estimates on strength in key unit
Reuters· 2026-02-04 13:11
Core Insights - Bio-Techne exceeded analysts' expectations for second-quarter revenue and profit, driven by strong demand for its products utilized in drug development [1] Company Performance - The company reported better-than-expected financial results for the second quarter, indicating robust operational performance [1] Market Demand - There is a significant demand for Bio-Techne's products in the drug development sector, which has positively impacted its financial outcomes [1]
Fox beats estimates for quarterly revenue
Reuters· 2026-02-04 13:05
Core Insights - Fox Corp exceeded Wall Street revenue expectations for the quarter, driven by strong advertising demand in its news and sports networks, as well as growth in its ad-supported streaming service Tubi [1] Group 1 - The company reported higher quarterly revenue, indicating robust performance in its advertising segments [1] - Advertising demand at Fox's news and sports networks contributed significantly to the revenue growth [1] - The ad-supported streaming service Tubi also experienced growth, further enhancing the company's overall revenue performance [1]
Wall Street broker Clear Street targets up to $11.8 billion valuation in US IPO
Reuters· 2026-02-04 13:01
Clear Street is targeting a valuation of as much as $11.8 billion in its initial public offering in the U.S., the securities and derivatives broker said on Wednesday, as the IPO market kicks into high gear. ...
Analysts ramp up gold forecasts as global uncertainties mount
Reuters· 2026-02-04 12:55
Core Viewpoint - Gold is projected to achieve another record performance in 2026, driven by geopolitical uncertainty and strong central bank purchases [1] Group 1: Market Drivers - Geopolitical uncertainty remains a significant factor influencing gold prices [1] - Robust buying from central banks is contributing to the bullish outlook for gold [1] Group 2: Analyst Forecasts - Analysts are increasing their forecasts for gold prices as market conditions evolve [1]
AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs
Reuters· 2026-02-04 12:51
AbbVie forecast 2026 profit above Wall Street estimates on Wednesday after posting a fourth-quarter results beat, fueled by strong demand for newer immunology drugs Skyrizi and Rinvoq and a smaller-th... ...
Equinor sold about 30% of its US gas on spot market during January price spike
Reuters· 2026-02-04 12:39
Core Viewpoint - Norway's Equinor successfully sold approximately 30% of its U.S. onshore natural gas assets on a spot basis in January, taking advantage of a cold snap that significantly increased demand and prices [1] Group 1: Company Performance - Equinor capitalized on market conditions by selling a substantial portion of its natural gas volumes, indicating effective management and strategic positioning in response to demand fluctuations [1] Group 2: Market Conditions - The cold snap in January led to a sharp rise in both demand and prices for natural gas, highlighting the volatility and responsiveness of the energy market to weather-related events [1]